Inhibition of poly(ADP-ribose)polymerase impairs Epstein Barr virus lytic cycle progression

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Mattiussi, Stefania ^a   Tempera, Italo ^a   Matusali, Giulia ^a   Mearini, Giulia ^a   Lenti, Luisa ^a   Fratarcangeli, Silvia ^a   Mosca, Luciana ^a   D'Erme, Maria ^a   Mattia, Elena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL LINE; DOWN REGULATION; DRUG INHIBITION; EPSTEIN BARR VIRUS; GENE EXPRESSION; MODULATION; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; UPREGULATION; VIRUS INFECTION;

EID: 37749024402     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-18     Document Type: Article

References (39)

1. AB Rickinson B KE, Epstein Barr Virus Philadelphia, P.A.: Lippincott Williams & Wilkins 2001
2. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. MA Lee ME Diamond JL Yates, J Virol 1999 73 2974 2982 10074147
3. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. B Tomkinson E Robertson E Kieff, J Virol 1993 67 2014 2025 8445720
4. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. S Henderson M Rowe C Gregory D Croom-Carter F Wang R Longnecker E Kieff A Rickinson, Cell 1991 65 1107 1115 10.1016/0092-8674(91)90007-L 1648447
5. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. AG Eliopoulos NJ Gallagher SM Blake CW Dawson LS Young, J Biol Chem 1999 274 16085 16096 10.1074/jbc.274.23.16085 10347160
6. Epstein-Barr virus: exploiting the immune system. DA Thorley-Lawson, Nat Rev Immunol 2001 1 75 82 10.1038/35095584 11905817
7. Induction of the lytic viral cycle in Epstein Barr virus carrying Burkitt lymphoma lines is accompanied by increased expression of major histocompatibility complex molecules. L Di Renzo J Avila-Carino E Klein, Immunol Lett 1993 38 207 214 10.1016/0165-2478(93)90008-P 8125529
8. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. J Luka B Kallin G Klein, Virology 1979 94 228 231 10.1016/0042-6822(79)90455-0 220786
9. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. K Takada Y Ono, J Virol 1989 63 445 449 2462063
10. Histone acetylation and reactivation of Epstein-Barr virus from latency. PJ Jenkins UK Binne PJ Farrell, J Virol 2000 74 710 720 10623733 10.1128/JVI.74.2.710-720.2000
11. Physiology and pathophysiology of poly(ADP-ribosyl)ation. A Burkle, Bioessays 2001 23 795 806 10.1002/bies.1115 11536292
12. Effect of poly(ADP-ribosyl)ation and Mg2+ ions on chromatin structure revealed by scanning force microscopy. M d'Erme G Yang E Sheagly F Palitti C Bustamante, Biochemistry 2001 40 10947 10955 10.1021/bi002742a 11551189
13. Poly(ADP-ribose): a co-regulator of DNA methylation? FR Althaus, Oncogene 2005 24 11 12 10.1038/sj.onc.1208382 15637586
14. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. A Tulin A Spradling, Science 2003 299 560 562 10.1126/science.1078764 12543974
15. NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. MY Kim S Mauro N Gevry JT Lis WL Kraus, Cell 2004 119 803 814 10.1016/j.cell.2004.11.002 15607977
16. Regulation of RNA polymerase II-dependent transcription by poly(ADP-ribosyl)ation of transcription factors. SL Oei J Griesenbeck M Schweiger M Ziegler, J Biol Chem 1998 273 31644 31647 10.1074/jbc.273.48.31644 9822623
17. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Y Gwack H Nakamura SH Lee J Souvlis JT Yustein S Gygi HJ Kung JU Jung, Mol Cell Biol 2003 23 8282 8294 14585985 10.1128/MCB.23.22.8282-8294.2003
18. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. HC Ha K Juluri Y Zhou S Leung M Hermankova SH Snyder, Proc Natl Acad Sci USA 2001 98 3364 3368 11248084 10.1073/pnas.051633498
19. RNA interference directed against Poly(ADP-Ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. M Kameoka S Nukuzuma A Itaya Y Tanaka K Ota K Ikuta K Yoshihara, J Virol 2004 78 8931 8934 15280503 10.1128/JVI.78.16.8931-8934.2004
20. Possible role of ADP-ribosylation of adenovirus core proteins in virus infection. CV Dery G de Murcia D Lamarre N Morin GG Poirier J Weber, Virus Res 1986 4 313 329 10.1016/0168-1702(86)90078-X 2941933
21. PARP-1 interaction with VP1 capsid protein regulates polyomavirus early gene expression. M Carbone A Reale A Di Sauro O Sthandier MI Garcia R Maione P Caiafa P Amati, J Mol Biol 2006 363 773 785 10.1016/j.jmb.2006.05.077 16979186
22. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. MP Egloff H Malet A Putics M Heinonen H Dutartre A Frangeul A Gruez V Campanacci C Cambillau J Ziebuhr, J Virol 2006 80 8493 8502 16912299 10.1128/JVI.00713-06
23. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. PW Rankin EL Jacobson RC Benjamin J Moss MK Jacobson, J Biol Chem 1989 264 4312 4317 2538435
24. Sequence analysis of Raji Epstein-Barr virus DNA. G Hatfull AT Bankier BG Barrell PJ Farrell, Virology 1988 164 334 340 10.1016/0042-6822(88)90546-6 2835854
25. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? PO Hassa SS Haenni M Elser MO Hottiger, Microbiol Mol Biol Rev 2006 70 789 829 16959969 10.1128/MMBR.00040-05
26. 3-Aminobenzamide induces cytoskeleton rearrangement in M14 melanoma cells. W Malorni G Rainaldi E Straface R Rivabene A Cossarizza M Capri D Monti C Franceschi, Biochem Biophys Res Commun 1994 202 915 922 10.1006/bbrc.1994.2017 8048965
27. Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation. M Masutani T Nozaki K Wakabayashi T Sugimura, Biochimie 1995 77 462 465 10.1016/0300-9084(96)88161-2 7578430
28. Interactions of Epstein-Barr Virus Origins of Replication with Nuclear Matrix in the Latent and in the Lytic Phases of Viral Infection. E Mattia M Ceridono S Chichiarelli M D'Erme, Virology 1999 262 9 17 10.1006/viro.1999.9854 10489336
29. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. GJ Inman UK Binne GA Parker PJ Farrell MJ Allday, J Virol 2001 75 2400 2410 11160743 10.1128/JVI.75.5.2400-2410.2001
30. Antiproliferative activity of 3-aminobenzamide in A431 carcinoma cells is associated with a target effect on cytoskeleton. R Tiozzo D Monti E Straface M Capri MA Croce G Rainaldi C Franceschi W Malorni, Biochem Biophys Res Commun 1996 225 826 832 10.1006/bbrc.1996.1258 8780697
31. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. S Aviel G Winberg M Massucci A Ciechanover, J Biol Chem 2000 275 23491 23499 10.1074/jbc.M002052200 10807912
32. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. O Ullrich T Reinheckel N Sitte R Hass T Grune KJ Davies, Proc Natl Acad Sci USA 1999 96 6223 6228 10339569 10.1073/pnas.96.11. 6223
33. Actin-based features negatively regulated by protein kinase C-epsilon. Y Li JM Urban ML Cayer HK Plummer 3rd CA Heckman, Am J Physiol Cell Physiol 2006 291 C1002 1013 10.1152/ajpcell.00079.2006 17035302
34. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. CW Dawson G Tramountanis AG Eliopoulos LS Young, J Biol Chem 2003 278 3694 3704 10.1074/jbc.M209840200 12446712
35. 3-Aminobenzamide protects cells from UV-B-induced apoptosis by acting on cytoskeleton and substrate adhesion. W Malorni R Rivabene E Straface G Rainaldi D Monti S Salvioli A Cossarizza C Franceschi, Biochem Biophys Res Commun 1995 207 715 724 10.1006/bbrc.1995.1246 7864864
36. Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure. GG Poirier G de Murcia J Jongstra-Bilen C Niedergang P Mandel, Proc Natl Acad Sci USA 1982 79 3423 3427 6808510 10.1073/pnas.79.11.3423
37. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. G Klein L Dombos B Gothoskar, Int J Cancer 1972 10 44 57 10.1002/ijc.2910100108 4122458
38. Down-regulation of proteolytic complexes following EBV activation in BL cells. G Matusali AD Leo R Gavioli L Bertelli LD Renzo E Mattia, Biochem Biophys Res Commun 2007 352 947 952 10.1016/j.bbrc.2006.11.127 17157806
39. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes. S Masciarelli B Mattioli R Galletti P Samoggia S Chichiarelli G Mearini E Mattia, Oncogene 2002 21 4166 4170 10.1038/sj.onc.1205515 12037673